yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.
Cloud Expo on Google News

2008 West
Data Direct
SOA, WOA and Cloud Computing: The New Frontier for Data Services
Red Hat
The Opening of Virtualization
User Environment Management – The Third Layer of the Desktop
Cloud Computing for Business Agility
CMIS: A Multi-Vendor Proposal for a Service-Based Content Management Interoperability Standard
Freedom OSS
Practical SOA” Max Yankelevich
Architecting an Enterprise Service Router (ESR) – A Cost-Effective Way to Scale SOA Across the Enterprise
Return on Assests: Bringing Visibility to your SOA Strategy
Managing Hybrid Endpoint Environments
Game-Changing Technology for Enterprise Clouds and Applications
Click For 2008 West
Event Webcasts

2008 West
Get ‘Rich’ Quick: Rapid Prototyping for RIA with ZERO Server Code
Keynote Systems
Designing for and Managing Performance in the New Frontier of Rich Internet Applications
How Can AJAX Improve Homeland Security?
Beyond Widgets: What a RIA Platform Should Offer
REAs: Rich Enterprise Applications
Click For 2008 Event Webcasts
Epicore BioNetworks Inc. Reports Quarter One Fiscal Year 2013

CALGARY, Alberta, November 19, 2012 /PRNewswire/ --

- for the period ended 30 September 2012, in US dollars

Gross profit grew 6% in quarter one (Q1) and revenue at $1.1 million was only 2% lower than last year's record Q1. Demand for shrimp and shrimp prices have remained high, which increase the demand for Epicore's productivity enhancing products. However, Early Mortality Syndrome in Asia has caused farm closures that have hurt Epicore sales throughout 2012.  The severe US Midwest drought drove up spot prices of agricultural commodities and reduced availability.  This event caused a shortage of critical raw materials for Epicore's dry feed products and produced finished feed stock-outs.  A significant volume of orders were missed in Q1 that will be filled in Q2. Epicore continued a major initiative to increase its science resources, which will position the Company for significant future growth and increase the reliability of its manufacturing operations.  Some Q1 highlights were:

  • Decrease in revenue of 2% over last year's record Q1
  • Increase in gross profit of 6% over Q1 last year
  • Increase in operating expenses of 14% over Q1 last year
  • Decrease in net income of 73% versus last year's Q1
  • Decrease in EBITDA of 42% versus last year's Q1
  • Increase in cash of $0.2 million from prior quarter
  • Achieved basic and diluted earnings per share of $0.001, down from $0.003 in prior year Q1.
  • Increased shareholders' equity 0.5% in the quarter to $4.9 million.

Epicore gross margin (gross profit as a percentage of sales) increased due to price increases and to sales mix  Operational expenses increased by 14% due to inflation, higher marketing travel expense, quality initiative expense and outside research expense.  Quarter one fiscal 2012 results include a US federal income tax expense of $0.04 million, along with $0.02 million for New Jersey and Ecuadorian taxes.  Net income of $0.02 million was lower than fiscal 2011 because of higher operating expenses, as the following results show (rounded to thousands in US dollars):

                         For the Quarter Ended September 30
                                     2012              2011
    Sales                       1,093,000         1,114,000
    Gross Profit                  665,000           628,000
    Operating Expenses            581,000           509,000
    Earnings Before Tax            75,000           126,000
    Income Tax Expense             58,000            62,000
    Net Income                     17,000            64,000
    EBITDA                         81,000           139,000

Cash at the end of September was $1.8 million, an increase of 12% over prior year quarter four.  With these funds, expected sales revenue growth and continued relatively low operating costs, management expects there will be sufficient cash to meet the fiscal year's financial requirements, to fund expansion of aquaculture and environmental remediation marketing efforts and to pursue new strategies for enhancing shareholder value.  In support of its growth strategy, the Company anticipates additional expenditure during fiscal 2013 in property, plant and equipment, through the addition of leased capital equipment and enhancements to its production facility in New Jersey, and in product development through its ongoing R&D programs.  This is expected to be financed by a combination of the Company's cash reserves, continued positive earnings and third-party financing.

The financial statements of the company have been prepared in accordance with International Financial Reporting Standards.  Epicore BioNetworks Inc. is a public corporation with a registered office in Calgary, Alberta, Canada and with shares listed on the TSX Venture Exchange (symbol EBN).  [Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.]

This press release contains forward-looking statements that involve significant risks and uncertainties.  The actual results, performance or achievements of the company might differ materially from the results, performance or achievements of the company expressed or implied by such forward-looking statements.  Such forward-looking statements include, without limitation, those regarding the future growth of the Company, expected future sales volumes, expected improvements in the quality and reliability of manufacturing operations, acceleration of the Company's penetration into new business areas, the development plans of the company and expectations respecting availability of financing for such development, the expected timing and results of such development and the expectation by management that there will be sufficient cash to meet the fiscal year's financial requirements.  We can provide no assurance that such development will proceed as currently anticipated, that the expected timing or results of such development will be realized or that the company will be able to generate sufficient cash to meet its obligations.  We are subject to various risks, including the uncertainties of product development, markets for our products and regulatory review, our need for additional capital to fund our operations, our reliance on collaborative partners, our history of losses, and other risks inherent in the biotechnology industry.

For further information:

Mr. William P. Long (Chief Executive Officer) USA. Tel: +1-609-267-9118, Email:


About PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest AJAXWorld RIA Stories
Interested in leveraging automation technologies and a cloud architecture to make developers more productive? Learn how PaaS can benefit your organization to help you streamline your application development, allow you to use existing infrastructure and improve operational efficie...
The OpenStack cloud operating system includes Trove, a database abstraction layer. Rather than applications connecting directly to a specific type of database, they connect to Trove, which in turn connects to one or more specific databases. One target database is Postgres Plus Cl...
"We provide a web application framework for building really sophisticated web applications that run on a browser without any installation need so we get used for biotech, defense, and banking applications," noted Charles Kendrick, CTO and Chief Architect at Isomorphic Software, i...
SYS-CON Events announced today that the "First Containers & Microservices Conference" will take place June 9-11, 2015, at the Javits Center in New York City. The “Second Containers & Microservices Conference” will take place November 3-5, 2015, at Santa Clara Convention Center, S...
DevOps Summit at Cloud Expo New York is offering a limited time FREE "Expo Plus" registration option in New York. On site registration price of $1,95 will be set to 'free' for delegates who register during special offer. To take advantage of this opportunity, attendees can use th...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)!

Advertise on this site! Contact advertising(at)! 201 802-3021

SYS-CON Featured Whitepapers